Chocolate company recalls product nationwide for undeclared allergen

NEW YORK (PIX11) — Chocolate products have been recalled nationwide due to potential undeclared milk allergens, according to the U.S. Food and Drug Administration.
The Pennsylvania-based distributor, Weaver Nut Company, Inc., has recalled its semi-sweet chocolate nonpareils with white or Christmas colored seeds, the advisory from the FDA says.
More Local News
People who have an allergy or severe sensitivity to milk could face serious or life-threatening allergic reactions if they consume the impacted products, the FDA warns. So far no illnesses have been reported.
The issue was discovered through a wholesale customer who filed a complaint saying the shipment was misaligned with the product specifications. Lab tests confirmed the presence of milk in the product.
More: Latest News from Around the Tri-State
Consumers who have purchased the recalled product are urged not to eat it if they have a milk allergy and return it to the place of purchase for a full refund.
Below is the list of lot codes for the affected chocolates.
47518 – Nonpareil, Semi-Sweet Chocolate (Christmas Seeds)
204206
204207
204208
204209
204212
224225
D2645 – Nonpareils, Semi-Sweet Chocolate (White Seeds)
204214-RL
204214
204215
224221
224222
224223
135215
135216
135217
135220
135221
145204
145205-1
145207-1
145210-1
Dominique Jack is a digital content producer from Brooklyn with more than five years of experience covering news. She joined PIX11 in 2024. More of her work can be found here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Forbes

26 minutes ago

• Forbes

Teens And Tweens Are Obsessed With Evereden's Skincare Brand For Babies—Now It Brings In $100 Million A Year

K imberley Ho's dining room table is almost always cluttered. On any given afternoon, the 35-year-old cofounder and CEO of Evereden, the New York-based cosmetics company for kids, risks ruining the white marble surface by testing bright-colored lipsticks in the shape of crayons and other beauty products aimed at Generation Alpha, or people born after 2010. 'We now have a laboratory with chemists, and research and development specialists,' says Ho, a member of the Forbes 30 Under 30 class of 2019, 'but I have never been willing to leave that part of the job—being product-obsessed is in our DNA.' Since cofounding Evereden in 2018 with her husband, Goldman Sachs alum Huang Lee, the brand now brings in $100 million in annual sales after finding a market for family-friendly skin and haircare products for babies and preteens. Many of her earliest customers were young mothers searching for safe products for their sensitive skin infants. Having raised some $40 million in venture capital funding between 2018 and 2021, Evereden, like its client base, has matured, expanding to include face serums, conditioners and perfumes engineered and marketed specifically to kids, preteens and pregnant mothers. While the company sells in Sephora across eight countries outside the United States, including Canada, Australia and the Philippines, most of its revenue comes from direct-to-consumer sales online. 'Billions of investment dollars have gone to women's beauty, cosmetics and skincare, but none of that innovation and investment really went into family skincare,' Ho says. 'That mismatch just didn't make sense for me.' Because of social media, Gen Alpha first interacts with a beauty product at 8 years old, according to a consumer trends study done last year by Ulta Beauty. That's a marked difference from younger Millennials and members of Generation Z, who on average first engaged with this industry at 15 and 12 years old, respectively. 'Clearly these young consumers are interested in skincare and are exposed to the internet…they probably need some help picking the right product,' says Dan Su, an analyst at Morningstar. 'Otherwise, they would be going to products that are designed for adult skin that may not really serve their needs.' 'The most interesting thing [about Evereden] is the tween space,' Su continues, 'which is catching the attention of the companies and investors and the beauty space.' Born and raised in Malaysia's bustling capital city Kuala Lumpar, Ho grew up with two entrepreneur parents, who founded a printing company. 'I was a literal startup baby in my mother's womb as she was hauling boxes because she couldn't afford to hire anybody,' she says. As a teenager, she became obsessed with getting into an Ivy League school—later pivoting to apply early to Stanford based primarily on campus photos of sunny California on the university's website. 'That was my first time in America, when I landed in SFO to attend Stanford,' she recalls. With clear, glassy skin and a quick smile, Ho presents as an Elle Woods-type, someone who has never considered anything to be impossible. During her first semester as an economics major at Stanford, she witnessed her peers trying to get in good with Goldman Sachs representatives at recruiting events. A few years later, in 2013, she became an investment banker at the elite Manhattan firm for a few years after college, later moving to the asset management firm Oaktree. At Oaktree, Ho first started seeing troubling patterns in several big beauty brands she worked with, ranging from billion-dollar lawsuits concerning undisclosed health risks, to an influx of indistinguishable direct-to-consumer brands, to smaller quality issues consistently swept under the rug. 'It was a lack of care and the integrity of some of these products that made me uncomfortable as a consumer, a beauty lover and someone who grew up with very sensitive skin,' Ho recalls. 'The light bulb moment came to me when my friends back home in Malaysia were starting families, and they would beg me to bring home these big American brands that were so-called 'clean and safe.' But because I was an investor behind the scenes in many of these brands, I knew that they were not as honest as they claim to be.' Having seen a giant hole in premium skincare products, she decided to leave Oaktree in 2017 to launch a high-end family cosmetics brand that became Evereden. Ho emailed her proposal to 50 dermatologists at top medical institutions to help her formulate her products. Dr. Joyce Teng, head of Stanford Medical School's pediatric dermatology department, invited her to pitch her company in person. Ho's concept immediately resonated with Teng, who shared the story of her youngest daughter's struggles with severe eczema. Teng soon came on board as the company's Chief Science Officer and was later joined by two other mothers who worked as doctors at Harvard Medical School. Cosmetics do not require FDA approval before going on the market, but sunscreen and over-the-counter eczema products do. Evereden receives FDA approval for these select items, and its team of doctors allows the company to make claims of being safe and 'clinically tested' for all other products across the board. Evereden launched in 2018 with one line of baby skincare products following a seed fundraising round led by Sidekick Partners, a Texas-based venture capital firm. In 2019, the company expanded into skincare for mothers, which included oils made to mitigate stretch marks. After surpassing $1 million in revenue in its first few years of business, the company started to add kids' skin- and haircare into the business. 'We expanded mostly because our customers were growing up and were saying, 'Hey, my baby's no longer an infant,' Ho says. 'In fact, they have an older sibling. Do you have products for children?'' The brand's presence in several niche subcategories is paramount to its growth, especially on Amazon. Within a few months of being on the market, the company's haircare products grew to No. 1 in Amazon's kids' hair category—a sector that had been relatively unexplored at the online retail giant. Products for preteens quickly became Evereden's fastest-growing segment. Kid Stuff: 'With our lab, our product development life cycle is three to six months,' Ho says. 'So, we're launching products three to four times faster than any one of our competitors.' Evereden Evereden raised money twice in 2021. The company's Series C round brought in $32 million and was led by Menlo Park-based GSR Ventures. Much of the funds raised in the Series C went toward building the company's own formulation lab and team of dedicated chemists. 'This not typical in the skincare or beauty industry,' Ho says. 'Typically, only the L'Oréals, Unilevers and P&Gs of the world have their own formulation labs.' Most emerging cosmetics brands—including Hailey Bieber's Rhode Beauty, which recently sold for $1 billion to Elf Beauty—use third-party chemists and labs that charge a fixed rate for formulation while simultaneously doing the same for dozens of other competing businesses. The industry standard to develop a new product with one of these outsourced companies is usually about 18 months. 'With our lab, our product development life cycle is three to six months,' Ho says. 'So, we're launching products three to four times faster than any one of our competitors.' Evereden began launching around 10 products a year starting 2021. Over the next four years, the company added enough products to address every need across its age categories, including hair, skin, body, fragrance and cosmetic products—effectively becoming a one-stop personal care shop for families. Since 2021, Amazon consistently delivered about half of Evereden's annual sales. Ho was also naturally conscious of the brand's presence internationally, given that she originally dreamed up her company after her friends in Malaysia asked her to send clean and safe American products for their newborns. While Evereden is in retail locations abroad, nearly all total sales still come from online purchases. The company had a net profit last year after reaching $100 million in sales. Within the last few years, Evereden's growth has coincided with marked increases in preteens flooding retailers and social media to test, buy and show off comically extensive skincare routines. Sephora's 2023 annual report stated that the number of its customers aged 9 to 12 doubled over the last five years, and the global children's cosmetic market was worth an estimated $1.6 billion in 2024. 'We are a multi-category, multi-generational brand, which I think is unique on the market,' Ho says. 'No single SKU makes up more than 20% of our total sales. And we have hero products in each of our categories.' While Evereden has reaped the benefits from the rise of so-called 'Sephora kids,' the brand's recent growth is not directly related to TikTok-influenced children. For one, Evereden isn't in major U.S. retailers such as Sephora or Ulta yet—although Ho hopes to secure a big retail partnership this year. Evereden's growth has also coincided with the rise of young kids developing an interest in high-end skincare brands such as Drunk Elephant and Laneige. Those brands often notably contain anti-aging components or exfoliating chemicals that dermatologists have said can cause considerable damage to young skin. Evereden is priced premium, especially next to a $5 bottle of Johnson's Baby Lotion, but the brand is relatively inexpensive compared to these adult brands piquing kids' interests. A 50 ml jar of Drunk Elephant's moisturizing cream costs $69, whereas a comparable cream from Evereden is less than half that at $28. Drunk Elephant reported sales of $120 million when it was acquired by Shiseido in 2019, but that figure dropped 65% in year-over-year sales in 2024, due in part to the losing its older consumer base as the brand soared with kids and tweens. 'I haven't really seen any specific brand gaining traction,' Morningstar's Su admits. 'I think it is reasonable to think that some of the large brands in the personal care and beauty space would be doing research and coming up with products. But it's just that it's very specific.' Su says that Evereden may face challenges since there might not be sufficient consumer data to help them with product development. She also notes that companies across the board are being given the chance to identify and understand young consumers based on their social media use. 'Every generation grows up faster than the previous one,' Ho says. 'Gen Alpha have grown up on social media, and they all have cell phones from eight years old.' On Evereden's TikTok account, there's a pinned video with half a million views that begins with two children—around six years old—dabbing one of Evereden's cream products on their faces, cosplaying as miniature versions of adult influencers who have made millions doing the same on their own accounts. It's somewhat uncanny seeing such small children expertly pose in front of the camera, but most of comments on the video address something along the lines of 'Can you please send me your products?' More from Forbes Forbes Patrick Schwarzenegger's Next Big Flex By Simone Melvin Forbes 30 Under 30 Europe Art & Culture 2025: Meet The Artists, Designers And Entrepreneurs Shaping Style And Taste By Simone Melvin Forbes How Crumbl Devoured America By Simone Melvin Forbes Hailey Bieber's Skin Care Firm Rhode To Be Acquired By E.L.F. Beauty In $1 Billion Deal By Gigi Zamora

Yahoo

36 minutes ago

• Yahoo

10 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

Electric vehicles, next-generation data centers, semiconductors, digital technology, and machine vision are just a few of the investment themes explored. Some of these companies have encountered near-term headwinds, creating attractive buying opportunities. All these stocks have powerful underlying secular growth drivers. These 10 stocks could mint the next wave of millionaires › Not all of the growth stocks featured here will likely deliver outsize returns, so it makes sense to spread portfolio risk around a collection of holdings. In that line of thought, here are 10 growth stock ideas for investors to consider. They range from a couple of high-profile household names, such as Tesla (NASDAQ: TSLA) and Delta Air Lines (NYSE: DAL), to companies like Navitas Semiconductor (NASDAQ: NVTS) and Synopsys (NASDAQ: SNPS), which are less well known. You might want to consider buying and holding any (or all) of these equities long-term. The key to the investment case for Tesla lies in its promised robotaxis and unsupervised full self-driving (FSD) software, which is scheduled to launch on a limited basis beginning this week. Tesla is already a highly successful automaker and the dominant player in electric vehicles (EVs) in the U.S., and robotaxis offer the prospect of transforming it into a company able to generate high-margin and recurring revenue from owning its robotaxi fleet or revenue sharing from Tesla's transformed fleet using Full Self-Driving (FSD) software. There's also the dedicated robotaxi, Cybercab, and the potential to sell FSD on a subscription basis. And all of it will be supported by Tesla's market-leading position in EVs and its ability to develop affordable EVs in the future. Nvidia partners Navitas Semiconductor and Vertiv (NYSE: VRT) and the next generation of data centers, namely 800-volt (V) high voltage direct current (HVDC), which I've discussed in more detail elsewhere, so investors with the time and inclination can peruse. Nvidia believes they will be more efficient, with lower maintenance costs and significantly lower costs of ownership. The new data centers, scheduled for 2027, employ a different power conversion method, and Navitas is developing Gallium Nitride (GaN) and Silicon Carbide (SiC) power semiconductors to enable more efficient power conversion in 800V HVDC data centers. Similarly, another Nvidia partner, and leading data center equipment provider, Vertiv, is developing critical power and cooling equipment and systems for the new data centers and expects to have them available in the second half of 2026, in time for the launch of the 800V HVDC data center in 2027. What makes both companies particularly interesting is that, unlike their rivals, they are more like pure plays in their end markets. For example, Navitas specializes in GaN and SiC chips for power conversion (not silicon), and 80% of Vertiv's revenue comes from data centers. Speaking of SiC and GaN chips, Aehr's (NASDAQ: AEHR) stock has soared recently on speculation that Navitas might be a customer for Aehr's testing and burn-in equipment. Aehr's equipment helps semiconductor manufacturers ensure quality and reliability throughout the manufacturing process. Aehr has struggled recently as its revenue at SiC customers, including ON Semiconductor, has declined in light of pullbacks in EV investment. Still, Aehr is making good progress in opening up and winning customers in new markets, including GaN semiconductors and semiconductors for artificial intelligence (AI) processing. Synopsys is a leader in electronic design automation software (used to design and verify chips), and its intended acquisition of engineering simulation and analysis company Ansys is a key event. The aim is to create a company offering design software, as well as simulation and analysis software to test the fruits of the design. It will also open up Synopsys' solutions to Ansys' wider range of end-market customers, particularly as semiconductors and electronics are increasingly being embedded in a range of new industries. The advanced materials company's lightweight composites are the future of the aerospace industry, as every new generation of airplane contains more composites. This means Hexcel (NYSE: HXL) can grow as airplane production increases (Airbus and Boeing have multiyear backlogs in place) and new, more composite-rich airplanes are developed. Hexcel has faced headwinds in recent years as Airbus' and Boeing's delivery rates have fallen short of expectations, but it's only a matter of time before they improve. Cognex (NASDAQ: CGNX) is another company with excellent long-term secular growth prospects (the use of machine vision in automated processes) that has suffered near-term headwinds (weakness in key end markets like automotive and consumer electronics). Still, this is a temporary slowdown in a long-term growth story. PTC (NASDAQ: PTC) provides computer-aided design (CAD), product lifecycle management (PLM), and other solutions essential to creating a so-called "digital thread" for a physical product as it moves from design through manufacturing, use, servicing, and ultimately disposal. As such, it's a leading player in the digitization of the industrial sector. Trimble's (NASDAQ: TRMB) precise positioning hardware (its origins) and growing software/services also make it a leading play on digitization. In Trimble's case, it's about integrating physical positioning with the digital world, such as in construction and infrastructure work, transportation, and geospatial activities. Through the use of advanced analytics in the digital world, Trimble's solutions can be integrated into its customers' daily workflows. Last but not least, Delta's growing mix of premium cabin revenue, loyalty program, co-brand card remuneration, and ability to adjust and compete in economy tickets when necessary means it's a much more diversified airline than a decade ago. In addition, as a network operator, it's much better positioned to deal with the growing cost pressures in the industry than low-cost carriers. Despite headwinds in 2025, it's ideally placed to generate value for shareholders over the long term. Ever feel like you missed the boat in buying the most successful stocks? Then you'll want to hear this. On rare occasions, our expert team of analysts issues a 'Double Down' stock recommendation for companies that they think are about to pop. If you're worried you've already missed your chance to invest, now is the best time to buy before it's too late. And the numbers speak for themselves: Nvidia: if you invested $1,000 when we doubled down in 2009, you'd have $373,066!* Apple: if you invested $1,000 when we doubled down in 2008, you'd have $38,158!* Netflix: if you invested $1,000 when we doubled down in 2004, you'd have $664,089!* Right now, we're issuing 'Double Down' alerts for three incredible companies, available when you join , and there may not be another chance like this anytime soon.*Stock Advisor returns as of June 9, 2025 Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Cognex, Nvidia, Synopsys, and Tesla. The Motley Fool recommends Ansys, Delta Air Lines, Hexcel, ON Semiconductor, PTC, and Trimble. The Motley Fool has a disclosure policy. 10 Brilliant Growth Stocks to Buy Now and Hold for the Long Term was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo

39 minutes ago

• Yahoo

One of America's Oldest Cheesemakers Could Be Yours—for $2.5 Million

Crowley Cheese, based in Vermont, has been around for more than 200 years, and the property of Galen Jones and his wife Jill Jones for the past 16. The business is considered Vermont's oldest active cheese factory and one of the oldest in the country. Galen and Jill Jones announced that Crowley was up for sale earlier this month, with an asking price of $2.5 of America's oldest small businesses is up for sale. It could be yours—if you have enough cheddar. Crowley Cheese, based in Healdville, Vt., has been around for more than 200 years, and the property of Galen Jones and his wife Jill Jones for the past 16. Now the company is on the block, with Galen, who is 68, ready to step away from the business of churning out handcrafted artisanal American cheese. "I'm an old man, and I'm ready to retire," he said. The asking price, $2.5 million, would get a buyer the factory, about 16 acres of surrounding land, cheesemaking equipment, the brand, and some 50,000 pounds of aged cheese. The business, which employs five people, is 'growing and profitable,' according to Galen Jones. A buyer would also get the recipe for Crowley's cheese, described as having yogurt-like qualities that distinguish it from other cheddars. It sells in blocks and wheels; an 8-ounce block starts at $10, while a 2.5 pound wheels starts at $50. The Crowley facility, which is considered Vermont's oldest active cheese factory and one of the oldest in the country, produces 30,000 to 40,000 pounds of aged cheddar cheese annually using a recipe that hasn't changed since 1824. Its cheese is shipped nationwide from Healdville, about a 150-mile drive northwest of Boston. The Joneses bought Crowley Cheese in 2009. Galen Jones knew people who were part of the previous investor group, he said, and happened to cross paths with the lead investor while working in digital media. (He declined to disclose the purchase price.) Reminded of the business, he looked it up online. 'We had a pretty terrible economy in 2009, and Crowley Cheese was also struggling,' Jones said. Unable to stop thinking about it, he reached out to the owners and soon visited the factory. 'Six weeks after that, my wife and I were operating this singular business, which was a simple factory in the middle of the countryside,' he said. 'It was serendipity, if you will.' The 'factory," a two-story historic farmhouse built in 1882 where cheese is handmade using raw milk with no additives or preservatives, includes a store and is open to visitors. The Joneses renovated the property and worked to improve production processes. Jones said he's received plenty of inquiries about the business since announcing its availability earlier this month. 'Some people are interested in the idea but not well equipped to take on the business,' he said. 'With others, there's serious interest.' The ideal buyer, he said, would be someone who could take "what we've been doing for the last 16 years to the next level,' he said. 'Cheesemaking is not for everyone. From my point of view, it's very important we find ownership that can successfully take the business forward.' Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data